The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2015

Filed:

Jun. 27, 2012
Applicants:

Tong-shuang LI, Burnaby, CA;

Ernest J. Mceachern, Burnaby, CA;

David J. Vocadlo, Burnaby, CA;

Yuanxi Zhou, Burnaby, CA;

Harold G. Selnick, West Point, PA (US);

Inventors:

Tong-Shuang Li, Burnaby, CA;

Ernest J. McEachern, Burnaby, CA;

David J. Vocadlo, Burnaby, CA;

Yuanxi Zhou, Burnaby, CA;

Harold G. Selnick, West Point, PA (US);

Assignees:

Alectos Therapeutics Inc., Burnaby, CA;

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 263/58 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 277/60 (2006.01); A61K 31/423 (2006.01); A61K 31/428 (2006.01); C07D 277/82 (2006.01); C12Q 1/37 (2006.01); C07D 263/52 (2006.01);
U.S. Cl.
CPC ...
C07D 277/60 (2013.01); C07D 263/52 (2013.01); C07D 263/58 (2013.01); C07D 277/82 (2013.01); C12Q 1/37 (2013.01); G01N 2333/924 (2013.01); G01N 2500/04 (2013.01);
Abstract

The invention provides compounds for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.


Find Patent Forward Citations

Loading…